Peter D Cole

24PUBLICATIONS
118CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Child and adolescent developmentApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 25, 2026
Copper depletion boosts CNS leukemia therapy by inhibiting nucleotide synthesis through impairment of mitochondrial complex IV activity.

|Feb 11, 2026
American Society of Hematology 2026 guidelines for management of relapsed/refractory acute lymphoblastic leukemia in adolescents and young adults.

Kristen M O'Dwyer, Lena E Winestone, Matthew C Cheung

|Feb 09, 2026
A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma.

Catherine Diefenbach, Opeyemi Jegede, Victoria Wang

|Jan 10, 2026
Trajectory of Neurocognitive Functioning in Children Treated for Acute Lymphoblastic Leukemia (ALL): Dana-Farber Cancer Institute ALL Consortium Study 16-001.

Alexandra Thrope, Sameera Ramjan, Charlie White

|Dec 23, 2025
Influence of ApoE genotype on doxorubicin-induced cognitive impairment in juvenile rats.

Chadni Patel, Frank Diglio, Benjamin H Durham

|Sep 04, 2025
Treatment-Related Changes in Cerebrospinal Fluid Markers of Oxidative Stress and Neurodegeneration during Therapy for Childhood Acute Lymphoblastic Leukemia.

Yongkyu Park, Nirajan K C, Jeremy Willekens

Pageof 4

Frequent Collaborators

9 joint publications

Jennifer Jg Welch

8 joint publications

Justine M Kahn

4 joint publications

Thai-Hoa Tran

4 joint publications

Stephen A Sands